[International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]. - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Z Kinder Jugendpsychiatr Psychother Année : 2021

[International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].

Heval Özgen
  • Fonction : Auteur
Renske Spijkerman
  • Fonction : Auteur
Moritz Noack
  • Fonction : Auteur
Martin Holtmann
  • Fonction : Auteur
Arnt S. A. Schellekens
  • Fonction : Auteur
Geurt van De Glind
  • Fonction : Auteur
Cleo L. Crunelle
  • Fonction : Auteur
Constanza Daigre Blanco
  • Fonction : Auteur
Søren Dalsgaard
  • Fonction : Auteur
Jacomine Den Boer
  • Fonction : Auteur
Geert Dom
  • Fonction : Auteur
Valsamma Eapen
  • Fonction : Auteur
Rafael A. González
  • Fonction : Auteur
Lara Grau-López
  • Fonction : Auteur
Annabeth P. Groenman
  • Fonction : Auteur
Malin Hemphälä
  • Fonction : Auteur
John G. Kasinathan
  • Fonction : Auteur
Sharlene S. Kaye
  • Fonction : Auteur
Frances R. Levin
  • Fonction : Auteur
Giovanni Martinotti
  • Fonction : Auteur
Frieda I. A. Matthys
  • Fonction : Auteur
Gergely Meszaros
  • Fonction : Auteur
Ashmita P. Munasur-Naidoo
  • Fonction : Auteur
Marianne Post
  • Fonction : Auteur
Sharon Rabinovitz
  • Fonction : Auteur
J. Antoni Ramos-Quiroga
  • Fonction : Auteur
Regina Sala
  • Fonction : Auteur
Abu Shafi
  • Fonction : Auteur
Ortal Slobodin
  • Fonction : Auteur
Wouter G. Staal
  • Fonction : Auteur
Ilse Truter
  • Fonction : Auteur
Michiel W. Van Kernebeek
  • Fonction : Auteur
Maria C. Velez-Pastrana
  • Fonction : Auteur
Jesse T. Young
  • Fonction : Auteur
Amy Yule
  • Fonction : Auteur
Wim van Den Brink
  • Fonction : Auteur

Résumé

International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder Abstract. Background: Childhood attention-deficit/hyperactivity disorder (ADHD) is a risk factor for substance misuse and substance use disorder (SUD) in adolescence and (early) adulthood. ADHD and SUD also frequently co-occur in treatment-seeking adolescents, which complicates diagnosis and treatment and is associated with poor treatment outcomes. Research on the effect of treatment of childhood ADHD on the prevention of adolescent SUD is inconclusive, and studies on the diagnosis and treatment of adolescents with ADHD and SUD are scarce. Thus, the available evidence is generally not sufficient to justify robust treatment recommendations. Objective: The aim of the study was to obtain a consensus statement based on a combination of scientific data and clinical experience. Method: A modified Delphi study to reach consensus based upon the combination of scientific data and clinical experience with a multidisciplinary group of 55 experts from 17 countries. The experts were asked to rate a set of statements on the effect of treatment of childhood ADHD on adolescent SUD and on the screening, diagnosis, and treatment of adolescents with comorbid ADHD and SUD. Results: After 3 iterative rounds of rating and adapting 37 statements, consensus was reached on 36 of these statements representing 6 domains: general (n = 4), risk of developing SUD (n = 3), screening and diagnosis (n = 7), psychosocial treatment (n = 5), pharmacological treatment (n = 11), and complementary treatments (n = 7). Routine screening is recommended for ADHD in adolescent patients in substance abuse treatment and for SUD in adolescent patients with ADHD in mental healthcare settings. Long-acting stimulants are recommended as the first-line treatment of ADHD in adolescents with concurrent ADHD and SUD, and pharmacotherapy should preferably be embedded in psychosocial treatment. The only remaining no-consensus statement concerned the requirement of abstinence before starting pharmacological treatment in adolescents with ADHD and concurrent SUD. In contrast to the majority, some experts required full abstinence before starting any pharmacological treatment, some were against the use of stimulants in the treatment of these patients (independent of abstinence), while some were against the alternative use of bupropion. Conclusion: This international consensus statement can be used by clinicians and patients together in a shared decision-making process to select the best interventions and to reach optimal outcomes in adolescent patients with concurrent ADHD and SUD.

Dates et versions

hal-04037045 , version 1 (20-03-2023)

Identifiants

Citer

Heval Özgen, Renske Spijkerman, Moritz Noack, Martin Holtmann, Arnt S. A. Schellekens, et al.. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].. Z Kinder Jugendpsychiatr Psychother, 2021, 50 (1), pp.54--67. ⟨10.1024/1422-4917/a000828⟩. ⟨hal-04037045⟩
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More